130625-89-7

Upstream product

• 130129-09-8 methyl (R)-5-hydroxyhex-2-ynoate 

Downstream Products

• 130625-99-9 Toluene-4-sulfonic acid (3R,5R)-6-benzyloxy-5-(tert-butyl-dimethyl-silanyloxy)-3-methyl-hexyl ester 
• 130626-00-5 ((1R,3R)-1-Benzyloxymethyl-3,7-dimethyl-octyloxy)-tert-butyl-dimethyl-silane 
• 130625-96-6 methyl (3S,5R)-6-benzyloxy-5-t-butyldimethylsiloxy-3-methylhexanoate 
• 130625-97-7 methyl (3S,5R)-6-benzyloxy-5-hydroxy-3-methylhexanoate 
• 130625-98-8 (3R,5R)-6-Benzyloxy-5-(tert-butyl-dimethyl-silanyloxy)-3-methyl-hexan-1-ol 
• 130626-02-7 (2R,4R)-1,2-O-benzylidene-4,8-dimethylnonane-1,2-diol 
• 130626-04-9 Benzoic acid (1R,3R)-1-bromomethyl-3,7-dimethyl-octyl ester 
• 130129-15-6 (4S,6R)-6-Benzyloxymethyl-4-methyl-tetrahydro-pyran-2-one 
• 120996-46-5 (R)-6-Benzyloxymethyl-5,6-dihydro-2-pyrone 

Relevant academic research and scientific papers

A CONVERGENT ENANTIOCONTROLLED ROUTE TO MEVALONOLACTONE AND VITAMIN E FROM (S)-O-BENZYLGLYCIDOL

A convergent enantiocontrolled route to (+) and (-)-mevalonolactones and vitamin E has been developed using (S)-O-benzylglycidol as the sole chiral block.